Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Intangibles (2016 - 2025)

Historic Intangibles for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $5.0 million.

  • OptimizeRx's Intangibles fell 1182.06% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 1182.06%. This contributed to the annual value of $5.5 million for FY2024, which is 9009.55% down from last year.
  • As of Q3 2025, OptimizeRx's Intangibles stood at $5.0 million, which was down 1182.06% from $5.2 million recorded in Q2 2025.
  • OptimizeRx's 5-year Intangibles high stood at $55.7 million for Q4 2023, and its period low was $3.1 million during Q3 2023.
  • Moreover, its 5-year median value for Intangibles was $5.4 million (2024), whereas its average is $11.2 million.
  • Over the last 5 years, OptimizeRx's Intangibles had its largest YoY gain of 35061.97% in 2024, and its largest YoY loss of 9009.55% in 2024.
  • Over the past 5 years, OptimizeRx's Intangibles (Quarter) stood at $17.5 million in 2021, then grew by 24.62% to $21.8 million in 2022, then surged by 155.2% to $55.7 million in 2023, then crashed by 90.1% to $5.5 million in 2024, then decreased by 9.14% to $5.0 million in 2025.
  • Its Intangibles was $5.0 million in Q3 2025, compared to $5.2 million in Q2 2025 and $5.3 million in Q1 2025.